STAAR Surgical Announces First Quarter Earnings Release Date and Conference Call
A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers, both using passcode 11088663#. To access the live webcast of the call, go to STAAR Surgical's website at http://www.staar.com. An archived webcast will also be available at http://www.staar.com.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL(TM), a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR's ICL is approved by the FDA for use in treating myopia, has received CE Marking and is approved for sale in 43 countries. More than 65,000 ICLs have been sold worldwide. More information is available at http://www.staar.com.
CONTACT: Investors Media EVC Group EVC Group Douglas Sherk, 415-896-6820 Jen Saunders, 646-201-5431 Jennifer Beugelmans, 646-201-5447
SOURCE STAAR Surgical Company
Investors, Douglas Sherk, +1-415-896-6820, or Jennifer Beugelmans, +1-646-201-5447; or Media, Jen Saunders, +1-646-201-5431, all of EVC Group, all for STAAR Surgical Company
http://www.staar.com